PLANO, Texas – MEDICALgorithmics and its U.S. subsidiary Medi-Lynx Cardiac Monitoring L.L.C. have received a broad patent for a new outpatient electrocardiogram monitoring and home-based cardiac tele-rehabilitation system, for use in both low- and high-risk cardiovascular patients. The system is currently under review with the U.S. Food and Drug Administration. “We’ve applied learnings from our world-class remote arrhythmia monitoring system, PocketECG, to advance remote cardiac rehabilitation, providing physicians with real-time streaming of the full disclosure ECG signal, physical activity and symptom monitoring, and holster quality reporting to more accurately monitor and care for their heart patients,” said Marek Dziubinski, CEO of MEDICALgorithmics, in a statement. The MEDICALgorithmics system and online portal provides physicians the ability to actively monitor patient recovery around-the-clock with a single lead smart phone-sized device. Exercise modules built into the monitor control the intensity of a patient’s exercise based on their real-time heart rate and a built-in accelerometer allows for better tracking of physical activity and more accurate heart rate analysis. All data is continuously transmitted to a physician or monitoring center, so the patient’s heart is constantly monitored and urgent issues are identified. If any ECG abnormalities are detected, the patient is informed to stop the exercise and contact medical personnel. Serious abnormalities are automatically detected and the physician/monitoring center alerted.
You are here: / / Companies receive patent for outpatient ECG system